Journal of Cancer Research and Therapeutics Close
 

Figure 7: Matrigel tube formation assay of mouse vascular endothelial cells MS1. After treated, respectively, with norcantharidin (2 μg/ml), diamminedichloroplatinum (2 μg/ml), and norcantharidin (1 μg/ml) plus diamminedichloroplatinum (1 μg/ml) for 72 h, and tubular structure in each group was quantified by manual counting. Norcantharidin plus diamminedichloroplatinum showed obvious inhibition on tube formation (P < 0.01). (a) Normal saline, (b) diamminedichloroplatinum, (c) norcantharidin, (d) diamminedichloroplatinum plus norcantharidin (n = 10)

Figure 7: Matrigel tube formation assay of mouse vascular endothelial cells MS1. After treated, respectively, with norcantharidin (2 μg/ml), diamminedichloroplatinum (2 μg/ml), and norcantharidin (1 μg/ml) plus diamminedichloroplatinum (1 μg/ml) for 72 h, and tubular structure in each group was quantified by manual counting. Norcantharidin plus diamminedichloroplatinum showed obvious inhibition on tube formation (<i>P</i> < 0.01). (a) Normal saline, (b) diamminedichloroplatinum, (c) norcantharidin, (d) diamminedichloroplatinum plus norcantharidin (<i>n</i> = 10)